Israeli innovation could transform treatment for millions living with enlarged prostate

The technology focuses ultrasound delivered through a device placed on the skin rather than through the urethra or rectum. Pesach Benson-TPS-IL A first-in-human clinical trial of an Israeli-developed technology for treating benign enlarged prostate has been conducted at Rambam Health Care Campus in Haifa, with researchers hoping it could eventually offer a less invasive alternative to existing surgical procedures. The technology focuses ultrasound delivered through a device placed on the skin rather than through the urethra or rectum. Developers say the approach could reduce the need for invasive surgery, general anesthesia and hospitalization for some patients. Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland, is one of the most common conditions affecting men over age 50. The condition can cause difficulty urinating, frequent urges to urinate and loss of bladder control.